The useful comparison is component profile, research-category fit, and attribution complexity
Author: Eric Patterson, LPC (No change) Medical Reviewer: Benjamin Troy, MD (No change) Primary Changes: Added summary block and star rating breakdown Author: Eric Patterson, LPC Medical Reviewer: Benjamin Troy, MD Your Voice Matters Leave your own reviews
The table shows different rates of depression and anxiety with different GLP-1 analogues
Acta Pharm Sin B 11:23962415 Sumida Y, Yoneda M (2018) Current and future pharmacological therapies for NAFLD/NASH
Proc Am Thorac Soc 7(5):325335 Kuruvilla ME, Lee FE, Lee GB (2019) Understanding asthma phenotypes, endotypes, and mechanisms of disease
Beyond cognitive deficits, PD patients frequently experience neuropsychiatric symptoms such as depression and anxiety, which result from widespread neurotransmitter dysregulation, including alterations in serotonin and norepinephrine levels